114 related articles for article (PubMed ID: 18714024)
1. Phosphorylation of 5-lipoxygenase at ser523 by protein kinase A determines whether pioglitazone and atorvastatin induce proinflammatory leukotriene B4 or anti-inflammatory 15-epi-lipoxin a4 production.
Ye Y; Lin Y; Perez-Polo JR; Uretsky BF; Ye Z; Tieu BC; Birnbaum Y
J Immunol; 2008 Sep; 181(5):3515-23. PubMed ID: 18714024
[TBL] [Abstract][Full Text] [Related]
2. Aspirin augments 15-epi-lipoxin A4 production by lipopolysaccharide, but blocks the pioglitazone and atorvastatin induction of 15-epi-lipoxin A4 in the rat heart.
Birnbaum Y; Ye Y; Lin Y; Freeberg SY; Huang MH; Perez-Polo JR; Uretsky BF
Prostaglandins Other Lipid Mediat; 2007 Feb; 83(1-2):89-98. PubMed ID: 17259075
[TBL] [Abstract][Full Text] [Related]
3. Augmentation of myocardial production of 15-epi-lipoxin-a4 by pioglitazone and atorvastatin in the rat.
Birnbaum Y; Ye Y; Lin Y; Freeberg SY; Nishi SP; Martinez JD; Huang MH; Uretsky BF; Perez-Polo JR
Circulation; 2006 Aug; 114(9):929-35. PubMed ID: 16908763
[TBL] [Abstract][Full Text] [Related]
4. Evidence that 5-lipoxygenase and acetylated cyclooxygenase 2-derived eicosanoids regulate leukocyte-endothelial adherence in response to aspirin.
Fiorucci S; Distrutti E; Mencarelli A; Morelli A; Laufor SA; Cirino G; Wallace JL
Br J Pharmacol; 2003 Aug; 139(7):1351-9. PubMed ID: 12890715
[TBL] [Abstract][Full Text] [Related]
5. Myocardial protection by pioglitazone, atorvastatin, and their combination: mechanisms and possible interactions.
Ye Y; Lin Y; Atar S; Huang MH; Perez-Polo JR; Uretsky BF; Birnbaum Y
Am J Physiol Heart Circ Physiol; 2006 Sep; 291(3):H1158-69. PubMed ID: 16603698
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of lipoxin A4 by 5-lipoxygenase mediates PPARgamma-dependent, neuroprotective effects of rosiglitazone in experimental stroke.
Sobrado M; Pereira MP; Ballesteros I; Hurtado O; Fernández-López D; Pradillo JM; Caso JR; Vivancos J; Nombela F; Serena J; Lizasoain I; Moro MA
J Neurosci; 2009 Mar; 29(12):3875-84. PubMed ID: 19321784
[TBL] [Abstract][Full Text] [Related]
7. Atorvastatin reduces plaque vulnerability in an atherosclerotic rabbit model by altering the 5-lipoxygenase pathway.
Zhou G; Ge S; Liu D; Xu G; Zhang R; Yin Q; Zhu W; Chen J; Liu X
Cardiology; 2010; 115(3):221-8. PubMed ID: 20234134
[TBL] [Abstract][Full Text] [Related]
8. Lipoxin A4 inhibits 5-lipoxygenase translocation and leukotrienes biosynthesis to exert a neuroprotective effect in cerebral ischemia/reperfusion injury.
Wu L; Miao S; Zou LB; Wu P; Hao H; Tang K; Zeng P; Xiong J; Li HH; Wu Q; Cai L; Ye DY
J Mol Neurosci; 2012 Sep; 48(1):185-200. PubMed ID: 22661361
[TBL] [Abstract][Full Text] [Related]
9. Blockade of cytosolic phospholipase A(2) and 5-lipoxygenase activation in neutrophils by a natural isoflavanquinone abruquinone A.
Hsu MF; Chang LC; Chen SC; Kuo SC; Lee HY; Lu MC; Wang JP
Eur J Pharmacol; 2008 Nov; 598(1-3):123-31. PubMed ID: 18834875
[TBL] [Abstract][Full Text] [Related]
10. The effect of pioglitazone treatment on 15-epi-lipoxin A4 levels in patients with type 2 diabetes.
Gutierrez AD; Sathyanarayana P; Konduru S; Ye Y; Birnbaum Y; Bajaj M
Atherosclerosis; 2012 Jul; 223(1):204-8. PubMed ID: 22687642
[TBL] [Abstract][Full Text] [Related]
11. The influence of acetylshikonin, a natural naphthoquinone, on the production of leukotriene B4 and thromboxane A2 in rat neutrophils.
Hsu MF; Chang LC; Huang LJ; Kuo SC; Lee HY; Lu MC; Wang JP
Eur J Pharmacol; 2009 Apr; 607(1-3):234-43. PubMed ID: 19232341
[TBL] [Abstract][Full Text] [Related]
12. Protein kinase A inhibits leukotriene synthesis by phosphorylation of 5-lipoxygenase on serine 523.
Luo M; Jones SM; Phare SM; Coffey MJ; Peters-Golden M; Brock TG
J Biol Chem; 2004 Oct; 279(40):41512-20. PubMed ID: 15280375
[TBL] [Abstract][Full Text] [Related]
13. The myocardial infarct size-limiting effect of sitagliptin is PKA-dependent, whereas the protective effect of pioglitazone is partially dependent on PKA.
Ye Y; Keyes KT; Zhang C; Perez-Polo JR; Lin Y; Birnbaum Y
Am J Physiol Heart Circ Physiol; 2010 May; 298(5):H1454-65. PubMed ID: 20207816
[TBL] [Abstract][Full Text] [Related]
14. Glucocorticoids sensitize rat placental inflammatory responses via inhibiting lipoxin A4 biosynthesis.
Zhang D; Li Y; Peng H; Liu H; Cheng Q; Cheng X; Zeng P; Wu P; Chen H; Huang Y; Ye D
Biol Reprod; 2014 Apr; 90(4):74. PubMed ID: 24571985
[TBL] [Abstract][Full Text] [Related]
15. Lipoxin A4 inhibits TNF-alpha-induced production of interleukins and proliferation of rat mesangial cells.
Wu SH; Lu C; Dong L; Zhou GP; He ZG; Chen ZQ
Kidney Int; 2005 Jul; 68(1):35-46. PubMed ID: 15954894
[TBL] [Abstract][Full Text] [Related]
16. Coactosin-like protein supports 5-lipoxygenase enzyme activity and up-regulates leukotriene A4 production.
Rakonjac M; Fischer L; Provost P; Werz O; Steinhilber D; Samuelsson B; Rådmark O
Proc Natl Acad Sci U S A; 2006 Aug; 103(35):13150-5. PubMed ID: 16924104
[TBL] [Abstract][Full Text] [Related]
17. Phosphorylation of serine 523 on 5-lipoxygenase in human B lymphocytes.
Mahshid Y; Markoutsa S; Dincbas-Renqvist V; Sürün D; Christensson B; Sander B; Björkholm M; Sorg BL; Rådmark O; Claesson HE
Prostaglandins Leukot Essent Fatty Acids; 2015 Sep; 100():33-40. PubMed ID: 26210919
[TBL] [Abstract][Full Text] [Related]
18. Roles of coactosin-like protein (CLP) and 5-lipoxygenase-activating protein (FLAP) in cellular leukotriene biosynthesis.
Basavarajappa D; Wan M; Lukic A; Steinhilber D; Samuelsson B; Rådmark O
Proc Natl Acad Sci U S A; 2014 Aug; 111(31):11371-6. PubMed ID: 25034252
[TBL] [Abstract][Full Text] [Related]
19. Atorvastatin prevents carbohydrate response element binding protein activation in the fructose-fed rat by activating protein kinase A.
Rodríguez-Calvo R; Barroso E; Serrano L; Coll T; Sánchez RM; Merlos M; Palomer X; Laguna JC; Vázquez-Carrera M
Hepatology; 2009 Jan; 49(1):106-15. PubMed ID: 19053045
[TBL] [Abstract][Full Text] [Related]
20. Low-dose treatment with atorvastatin leads to anti-oxidative and anti-inflammatory effects in diabetes mellitus.
Riad A; Du J; Stiehl S; Westermann D; Mohr Z; Sobirey M; Doehner W; Adams V; Pauschinger M; Schultheiss HP; Tschöpe C
Eur J Pharmacol; 2007 Aug; 569(3):204-11. PubMed ID: 17669395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
